Skip to main navigation Skip to search Skip to main content

Emerging issues in probiotic safety: 2023 perspectives

  • Daniel Merenstein
  • , Bruno Pot
  • , Gregory Leyer
  • , Arthur C. Ouwehand
  • , Geoffrey A. Preidis
  • , Christopher A. Elkins
  • , Colin Hill
  • , Zachery T. Lewis
  • , Andrea L. Shane
  • , Niv Zmora
  • , Mariya I. Petrova
  • , Maria Carmen Collado
  • , Lorenzo Morelli
  • , Gina A. Montoya
  • , Hania Szajewska
  • , Daniel J. Tancredi
  • , Mary Ellen Sanders
  • Georgetown University
  • Yakult Europe BV
  • Chr. Hansen, Inc.
  • International Flavors & Fragrances
  • Texas Children's Hospital Houston
  • Centers for Disease Control and Prevention
  • Synbiotic Health
  • Emory University
  • Weizmann Institute of Science
  • Winclove Probiotics
  • Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC)
  • Catholic University of the Sacred Heart
  • Nestle
  • Medical University of Warsaw
  • University of California at Davis
  • International Scientific Association for Probiotics and Prebiotics

Research output: Contribution to journalReview articlepeer-review

Abstract

Probiotics are used for both generally healthy consumers and in clinical settings. However, theoretical and proven adverse events from probiotic consumption exist. New probiotic strains and products, as well as expanding use of probiotics into vulnerable populations, warrants concise, and actionable recommendations on how to work toward their safe and effective use. The International Scientific Association for Probiotics and Prebiotics convened a meeting to discuss and produce evidence-based recommendations on potential acute and long-term risks, risks to vulnerable populations, the importance for probiotic product quality to match the needs of vulnerable populations, and the need for adverse event reporting related to probiotic use. The importance of whole genome sequencing, which enables determination of virulence, toxin, and antibiotic resistance genes, as well as clear assignment of species and strain identity, is emphasized. We present recommendations to guide the scientific and medical community on judging probiotic safety.

Original languageEnglish
Article number2185034
JournalGut Microbes
Volume15
Issue number1
DOIs
Publication statusPublished - 2023

Keywords

  • antibiotic resistance
  • genome sequencing
  • International Scientific Association for Probiotics and Prebiotics
  • ISAPP
  • live biotherapeutic products
  • microbiome
  • microbiota
  • next-generation probiotics
  • Probiotic
  • safety

Fingerprint

Dive into the research topics of 'Emerging issues in probiotic safety: 2023 perspectives'. Together they form a unique fingerprint.

Cite this